HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 129 filers reported holding HARROW HEALTH INC in Q3 2023. The put-call ratio across all filers is 5.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,534,150 | -24.1% | 3,795,000 | +0.5% | 17.74% | +3.2% |
| Q2 2023 | $71,876,000 | -10.0% | 3,775,000 | 0.0% | 17.19% | -28.1% |
| Q1 2023 | $79,879,000 | +43.4% | 3,775,000 | 0.0% | 23.92% | +23.5% |
| Q4 2022 | $55,719,000 | +38.1% | 3,775,000 | +12.9% | 19.38% | +16.2% |
| Q3 2022 | $40,360,000 | +66.4% | 3,343,817 | +0.3% | 16.67% | +52.4% |
| Q2 2022 | $24,262,000 | +8.1% | 3,332,732 | +1.3% | 10.94% | +56.9% |
| Q1 2022 | $22,447,000 | -20.9% | 3,291,343 | +0.2% | 6.97% | +15.8% |
| Q4 2021 | $28,382,000 | -5.0% | 3,285,000 | 0.0% | 6.02% | +7.9% |
| Q3 2021 | $29,861,000 | +2.4% | 3,285,000 | +4.6% | 5.58% | +15.1% |
| Q2 2021 | $29,171,000 | +41.0% | 3,140,000 | +2.4% | 4.84% | +59.4% |
| Q1 2021 | $20,692,000 | -1.6% | 3,065,416 | 0.0% | 3.04% | +10.6% |
| Q4 2020 | $21,029,000 | +27.1% | 3,065,416 | +3.6% | 2.75% | -15.1% |
| Q3 2020 | $16,541,000 | +17.2% | 2,959,000 | +9.2% | 3.24% | +13.5% |
| Q2 2020 | $14,119,000 | – | 2,710,000 | – | 2.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |